We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

By LabMedica International staff writers
Posted on 22 Apr 2024

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. More...

T cells are commonly associated with acute cellular rejection (ACR), where T cells attack the transplanted organ. To counteract this, organ transplant recipients must take immunosuppressive drugs indefinitely. Despite this, rejection episodes can still occur, necessitating long-term monitoring. Currently, ACR detection in transplant patients requires repeated surgical biopsies throughout their lives. These biopsies are vital for monitoring ACR and adjusting treatments accordingly, yet they diminish the patient's quality of life and can cause severe complications. Now, the discovery of a promising biomarker has paved the way for a blood test for ACR.

Researchers at Yale School of Medicine (New Haven, CT, USA) have achieved a potential breakthrough in monitoring ACR via blood tests by focusing on T cell exosomes, which are significantly altered during ACR. These extracellular vesicles play a crucial role in cell communication and transport various proteins and RNAs. Although T cells themselves do not show detectable changes in the bloodstream during ACR, their exosomes do. Isolating these exosomes for study presents challenges due to the mixture of exosomes from various cells in the blood. The research team has developed a method to enrich T cell exosomes from blood samples, providing detailed insights into the changes in their cargo during ACR. Using advanced techniques like RT-qPCR for RNA and western blot for protein analysis, they have identified significant differences in T cell exosomes from mouse models of heart transplantation undergoing ACR.

This methodology was also applied to human heart transplant patients, confirming similar alterations in T cell exosomes in the case of ACR patients. The study demonstrates that T cell exosomes not only indicate the occurrence of ACR but may also contribute to the damage in transplant rejection. The ongoing research aims to validate this biomarker in a larger cohort of heart transplant recipients and to extend the findings to lung transplant monitoring. Ultimately, this could lead to replacing invasive surgical biopsies with a simple blood test for detecting ACR, enhancing the quality of life and potentially saving more lives by facilitating timely interventions.

“I’m imagining a future in which a heart transplant patient could go once a month to a local [diagnostics] lab,” said Prashanth Vallabhajosyula, MD, MS, associate professor of surgery (cardiac) and the study’s principal investigator. “They don’t have to come to a cath lab and get a biopsy of their transplanted heart. They just go to a local lab, give a blood sample, and go home, and clinicians would receive molecular information about the overall immune health of the transplanted heart.”

Related Links:
Yale School of Medicine


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
Pipet Controller
Stripettor Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.